How to contact us

Messages / Inquiries / Contact persons

Notes on enquiries

  • Prior to contacting us, please visit our website for detailed information, as we may have answered your question already.
  • E-mail inquiries should use functional E-mail addresses listed below, so a quick answer is guaranteed even in the case of absences of individual employees.
  • For specific or urgent issues topics and personal contact please use email adressed  with  


AGES MEA is not in charge for following topics:

  • BASG or AGES MEA does not make any individual therapy recommendations. The treatment and the treatment regime is determined by the physician individually for the patient and subject solely the responsibility of the treating physician.
  • Reimbursement of medicines fall within the competence of Hauptverband der österreichischen Sozialversicherungsträger.


 Media Related Contacts

Media enquiries relating activities including press releases, press articles and interviews: 

Functional E-Mail Addresses

Active Substance Master File (ASMF, EDMF)asmfbasg.gvat 
Analytics - chemical-pharmaceuticalbasg.cpaabasg.gvat
Analytics - biological (batch releases)chargenbasg.gvat
Boderline and classification issuesabgrenzungbasg.gvat
BREXIT questions and applicationrmsbasg.gvat
Centralised Procedures (Scientific Office)sciobasg.gvat
Certificate of a Pharmaceutical Productcppbasg.gvat
CESP - technical issuescespbasg.gvat
Clinical trials on medicinal productsclinicaltrialsbasg.gvat
Clinical trials on medical devices clinicaltrialsbasg.gvat
Compassionate usecompassionate-usebasg.gvat
Dunning activities, due datesbasg.mahnungenbasg.gvat
DHCP and education materialdhpc-embasg.gvat
Electronic submission (inquiries and technical validation)eSubmissionbasg.gvat
ERP European Reference Product inquiries  (AT not RMS)hotline.euregulatorybasg.gvat
eServices - technical issuesbasg-eservicesbasg.gvat
Fee and invoice issuesbasg.fakturierungbasg.gvat
Free Sales Certificate for medical devicesfscbasg.gvat
GLP Good Laboratory Practiceglpbasg.gvat
Herbal medicinesbasg-hevebasg.gvat
Innovative medicinal productsinnovationbasg.gvat
Inquiries (general)basg_anfragenbasg.gvat
Inspections of bioequivalence studiesgcp-bebasg.gvat
Inspections of computer-based systemsgxp-cgsbasg.gvat
Inspections according to GLPglpbasg.gvat
Medical devicesmedizinproduktebasg.gvat
Medicine shortagesmedicineshortagebasg.gvat
Naming AT=RMSrmsbasg.gvat
Naming AT=CMS and nationalhotline.euregulatorybasg.gvat
National Scientific Advice (NASA)scientificadvicebasg.gvat
Non-interventional studies (NIS)nisbasg.gvat
Paediatric worksharing Art 45 and 46kinderarzneimittelbasg.gvat
Parallel importreferencebasg.gvat
Pharmacovigilance - humanpharm-vigilanzbasg.gvat
Pharmacovigilance - veterinarybasg-v-phvbasg.gvat
Pharmacovigilance PHV implementationpv-implementationbasg.gvat
Pipeline meeting - contactbasg-agesmedizinmarktaufsichtbasg.gvat
PMF - Plasma Master Filepmfbasg.gvat
Praise or criticismlob_und_tadelbasg.gvat
PSUR and MRPCASE_PHVbasg.gvat
Public Relationspresse-basgbasg.gvat
QRD inquiriesqrdbasg.gvat
Quality deficiency reportsam-qualitaetsmangelbasg.gvat
Quality management of the Austrian Medicines and Medical Devices Agencyqmgtbasg.gvat
Reference product AT=RMSrmsbasg.gvat
Regulatory, general inquirieshotline.euregulatorybasg.gvat
Regulatory, product-related AT=RMSrmsbasg.gvat
Regulatory, product-related AT=CMSbasg-cmsbasg.gvat
Regulatory, product-related, national in ATnatbasg.gvat
Regulatory issues - central procedurecpbasg.gvat
Scientific Advicescientificadvicebasg.gvat
Side effects - reporting on human medicinesnebenwirkungbasg.gvat
Sunset clausee-Service-Portal
Veterinary medicines - assessmentbasg-hevebasg.gvat


BASG - Federal Office for Safety in Health Care

Head of the Office:

Mag. iur. Thomas Reichhart


AGES MEA - Austrian Medicines and Medical Devices Agency

Head of AGES MEA:

Dipl.-Ing. Dr. Christa Wirthumer-Hoche


Traisengasse 5, 1200 Wien


Institutes of AGES MEA:


Institute Marketing Authorisation of Medicinal Products & Lifecycle ManagementMag. Dr. Peter Platzer
Institute Assessment & AnalyticsDr. Gerhard Beck
Institute SurveillanceDipl.-Ing. Dr. Ronald Bauer


Institute Marketing Authorisation of Medicinal Products & Lifecycle Management (LCM)

Head: Mag. Dr. Peter Platzer


Traisengasse 5, 1200 Wien

Regulatory issues

General enquiries:hotline.euregulatorybasg.gvat
Regulatory, product-related AT=RMS:rmsbasg.gvat
Regulatory, product-related AT=CMS:basg-cmsbasg.gvat
Regulatory, product-related, national in AT:natbasg.gvat

For MRP/DCP, please see also the list of Austrian contact points  at the CMDh website. 

Allocation Scheme



Quality Assessment of Human and Veterinary Medicinal Products (chemical and defined biological Medicinal Products*)

DI Susanne Stottersusanne.stotteragesat
DI Dr. Wolfgang Herzogwolfgang.herzogagesat

* such as Heparins, low molecular Heparins, Insulin, Pancreatin, Menotrophin, Botulinum toxin, Hyaluroidase, enzyme/Lysate of microorganism, Lactobacillus spp., Streptococcus spp., Phospholipids bovine/porcine (see also CMDh Overview of biological active substances of non-recombinant origin)





Quality and Medical assessment of Herbal and Homeopathic Medicinal Productsin Department HEVE

Univ.-Doz. Dr. Reinhard Längerreinhard.laengeragesat
Dr. Astrid Obmannastrid.obmannagesat



Medical Assessment of national, MRP and DCP procedures for human medicinal products (except Biologics, Herbals) in Department MRAT


Dr. Ingeborg Gerngrossingeborg.gerngrossagesat
Dr. Jascha Hörnischjascha.hoernischagesat



Medical Assessment of national, MRP and DCP procedures for veterinary medicinal products  in Department HEVE   


Dr. Gabriele Rothmüller gabriele.rothmuelleragesat
Mag. Ingrid Langneringrid.langneragesat


Institute Assessment & Analytics (BGA)

Head: Dr. Gerhard Beck




Assessment - Traisengasse 5, 1200 Wien

Medical assessment of human medices in Department CASE 


Dr. Barbara Tucekbarbara.tucekagesat
Dr. Jan Neuhauserjan.neuhauseragesat


Centralised procedures 

Dr. Jan Neuhauserjan.neuhauseragesat

Biologicals (national, MRP-/DCP-, and centralised procedures)


Dr. Brigitte Müllerbrigitte.muelleragesat




Dr. Barbara Tucekpharm-vigilanzbasg.gvat


Biologicals, Preclinical and Statistical Assessment


Dr. Barbara Zemannbarbara.zemannagesat
Dr. Günter Waxeneckerguenter.waxeneckeragesat



OMCL Laboratory - Possingergasse 38, 1160 Wien


Analytics biological medicines 


Dipl.-Ing. Heidemarie Schindlchargenbasg.gvat




OMCL Laboratory - Zimmermanngasse 3, 1090 Wien


Analytics  chemical-pharmaceutical medicines


Mag. Roman Macasbasg.cpaabasg.gvat
Austrian Pharmacopoeiabasg.oeabbasg.gvat



Institute Surveillance (INS)

Head: Dipl.- Ing. Dr. Ronald Bauer




Traisengasse 5, 1200 Wien

Departments for 


GMP/GDPMag. Andreas Kraßnigg
Clinical trials Dr. Ilona Reischl
Medical Devices Market Surveillance 
Dipl.-Ing. Andreas Amon
Blood, Tissue & VigilanceMag. Dr. Verena Plattner



Pharmacovigilance contacts




Single case and signal detection of human medicines


Mag. Katharina Weberpharm-vigilanzbasg.gvat
Fax.Nr.:+43 (0)50 555 36207


Pharmacovigilance veterinary medicines


Dr. Anja Kotschwarbasg-v-phvbasg.gvat



Regulatory issues:


Periodic Safety Update Report and Risk Manangement Plan


Dr. Sonja


Pharmacovigilance Implementation / DHCP and Educational Material

Ing. Veronika Heimlich, BScpv-implementationbasg.gvat
Dr. Ulrike Rehbergerpv-implementationbasg.gvat
Mag. Rudolf Schranzdhpc-embasg.gvat

Availability of all MEA employees

Praise and criticism

For complaints or positive feedbacks to activities of the BASG and AGES MEA or its staff members, please contact us by e-mail

Incoming complaints are checked if they are in the responsibility of the Federal Office for Safety in Health Care (BASG) or the Austrian Medicines and Medical Devices Agency (AGES MEA). You will receive on short notice feedback on the outcome of this check as well as information regarding the actions implemented following justified complaints in our responsibility, as applicable.

Emergency Contact Number +43 (0) 664 831 28 43

Please note: The emergency number should only be used for emergencies according to art. 70 Medical Devices Act or for emergencies within the meaning of art. 10 Pharmacovigilance Regulation. An emergency is considered to be an immediate danger to life or a serious and substantial threat to health.

All other questions can be adressed to other contact points listed here on this page.


24-hour emergency telephone service for pharmacogivilance responsible persons and for safety officers for medical devices.
Tel.: +43 (0) 664 831 28 43


keyboard_arrow_up to top